Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Conexeu Sciences Inc.22.1remove | OS Therapies Inc10.6remove | FEMASYS INC10.5remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 22.1 | 10.6 | 10.5 |
| IPO signal score | 44.1 | 21.2 | 20.9 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | ACCELERATING+23.8 | ACCELERATING+11.2 | ACCELERATING+10.9 |
| Company | |||
| Stage | public | private | filed |
| Sector | Technology | Technology | Technology |
| Headquarters | RENO, United States | Grasonville, United States | SUWANEE, United States |
| Founded | 2022 | not on record | not on record |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $151K | $5M | $30M |
| Latest round | Private Placement $89K | Private Placement $5M | Private Placement $30M |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 30 | 36 | 30 |
| Confidence | 80% | 68% | 60% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.